Acetylcholinesterase reactivators are crucial antidotes for the treatment of organophosphate intoxication. Among the organophosphates, with the exception of soman, tabun (GA) intoxications are the least responsive to treatment with commercially available therapeutics. A rational design was used to increase reactivation ability and decrease the toxicity of the novel reactivator. (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203) has better properties than previously tested compounds in vitro and, therefore, is a potential candidate for the treatment of GA intoxication in vivo.

Department of Toxicology Faculty of Military Health Sciences University of Defense Hradec Kralove

References provided by Crossref.org

Brominated oxime nucleophiles are efficiently reactivating cholinesterases inhibited by nerve agents

Charged pyridinium oximes with thiocarboxamide moiety are equally or less effective reactivators of organophosphate-inhibited cholinesterases compared to analogous carboxamides

Acute Toxic Injuries of Rat's Visceral Tissues Induced by Different Oximes

In Vitro Evaluation of Neutral Aryloximes as Reactivators for Electrophorus eel Acetylcholinesterase Inhibited by Paraoxon

Toxic Injury to Muscle Tissue of Rats Following Acute Oximes Exposure

Novel Group of AChE Reactivators-Synthesis, In Vitro Reactivation and Molecular Docking Study

Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisonings

A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase

A 7-methoxytacrine-4-pyridinealdoxime hybrid as a novel prophylactic agent with reactivation properties in organophosphate intoxication

Effect of seven newly synthesized and currently available oxime cholinesterase reactivators on cyclosarin-intoxicated rats

The present approaches to the development of prophylactic and therapeutic antidotes against nerve agents